215 related articles for article (PubMed ID: 30339814)
1. Isoliquiritigenin-mediated p62/SQSTM1 induction regulates apoptotic potential through attenuation of caspase-8 activation in colorectal cancer cells.
Jin H; Seo GS; Lee SH
Eur J Pharmacol; 2018 Dec; 841():90-97. PubMed ID: 30339814
[TBL] [Abstract][Full Text] [Related]
2. Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth.
Chen HY; Huang TC; Shieh TM; Wu CH; Lin LC; Hsia SM
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934130
[TBL] [Abstract][Full Text] [Related]
3. Isoliquiritigenin inhibits the proliferation of human renal carcinoma Caki cells through the ROS-mediated regulation of the Jak2/STAT3 pathway.
Kim DH; Park JE; Chae IG; Park G; Lee S; Chun KS
Oncol Rep; 2017 Jul; 38(1):575-583. PubMed ID: 28560439
[TBL] [Abstract][Full Text] [Related]
4. 13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity Against Oral Cancer Cells Through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts.
Liu YC; Peng BR; Hsu KC; El-Shazly M; Shih SP; Lin TE; Kuo FW; Chou YC; Lin HY; Lu MC
Mar Drugs; 2020 Jul; 18(8):. PubMed ID: 32718084
[TBL] [Abstract][Full Text] [Related]
5. Triggering apoptosis by oroxylin A through caspase-8 activation and p62/SQSTM1 proteolysis.
Zhao Y; Zhu Q; Bu X; Zhou Y; Bai D; Guo Q; Gao Y; Lu N
Redox Biol; 2020 Jan; 29():101392. PubMed ID: 31926620
[TBL] [Abstract][Full Text] [Related]
6. p62 aggregates mediated Caspase 8 activation is responsible for progression of ovarian cancer.
Yan XY; Zhong XR; Yu SH; Zhang LC; Liu YN; Zhang Y; Sun LK; Su J
J Cell Mol Med; 2019 Jun; 23(6):4030-4042. PubMed ID: 30941888
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin regulates isoliquiritigenin-induced autophagic and apoptotic cell death in adenoid cystic carcinoma cells.
Chen G; Hu X; Zhang W; Xu N; Wang FQ; Jia J; Zhang WF; Sun ZJ; Zhao YF
Apoptosis; 2012 Jan; 17(1):90-101. PubMed ID: 21956714
[TBL] [Abstract][Full Text] [Related]
8. PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism.
Serrano-Saenz S; Palacios C; Delgado-Bellido D; López-Jiménez L; Garcia-Diaz A; Soto-Serrano Y; Casal JI; Bartolomé RA; Fernández-Luna JL; López-Rivas A; Oliver FJ
Cell Death Dis; 2019 Jan; 10(2):51. PubMed ID: 30718520
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
10. Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice.
Wu CH; Chen HY; Wang CW; Shieh TM; Huang TC; Lin LC; Wang KL; Hsia SM
Oncotarget; 2016 Nov; 7(45):73432-73447. PubMed ID: 27708238
[TBL] [Abstract][Full Text] [Related]
11. p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor.
Zhang J; Yang S; Xu B; Wang T; Zheng Y; Liu F; Ren F; Jiang J; Shi H; Zou B; Lu X; Lu S; Dong L
Cell Prolif; 2019 May; 52(3):e12585. PubMed ID: 30793399
[TBL] [Abstract][Full Text] [Related]
12. Synergistic anticancer effect of docosahexaenoic acid and isoliquiritigenin on human colorectal cancer cells through ROS-mediated regulation of the JNK and cytochrome c release.
Jin H; Kim HS; Yu ST; Shin SR; Lee SH; Seo GS
Mol Biol Rep; 2021 Feb; 48(2):1171-1180. PubMed ID: 33502699
[TBL] [Abstract][Full Text] [Related]
13. p62/SQSTM1 is involved in caspase-8 associated cell death induced by proteasome inhibitor MG132 in U87MG cells.
Zeng RX; Zhang YB; Fan Y; Wu GL
Cell Biol Int; 2014 Oct; 38(10):1221-6. PubMed ID: 24805111
[TBL] [Abstract][Full Text] [Related]
14. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming.
Saito T; Ichimura Y; Taguchi K; Suzuki T; Mizushima T; Takagi K; Hirose Y; Nagahashi M; Iso T; Fukutomi T; Ohishi M; Endo K; Uemura T; Nishito Y; Okuda S; Obata M; Kouno T; Imamura R; Tada Y; Obata R; Yasuda D; Takahashi K; Fujimura T; Pi J; Lee MS; Ueno T; Ohe T; Mashino T; Wakai T; Kojima H; Okabe T; Nagano T; Motohashi H; Waguri S; Soga T; Yamamoto M; Tanaka K; Komatsu M
Nat Commun; 2016 Jun; 7():12030. PubMed ID: 27345495
[TBL] [Abstract][Full Text] [Related]
15. Autophagy protein p62/SQSTM1 is involved in HAMLET-induced cell death by modulating apotosis in U87MG cells.
Zhang YB; Gong JL; Xing TY; Zheng SP; Ding W
Cell Death Dis; 2013 Mar; 4(3):e550. PubMed ID: 23519119
[TBL] [Abstract][Full Text] [Related]
16. Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition.
Shi C; Pan BQ; Shi F; Xie ZH; Jiang YY; Shang L; Zhang Y; Xu X; Cai Y; Hao JJ; Wang MR
Oncogene; 2018 Jun; 37(24):3260-3274. PubMed ID: 29551772
[TBL] [Abstract][Full Text] [Related]
17. Shallot and licorice constituent isoliquiritigenin arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and initiation of the mitochondrial system in human cervical carcinoma HeLa cells.
Hsu YL; Chia CC; Chen PJ; Huang SE; Huang SC; Kuo PL
Mol Nutr Food Res; 2009 Jul; 53(7):826-35. PubMed ID: 19536869
[TBL] [Abstract][Full Text] [Related]
18. Escin-induced DNA damage promotes escin-induced apoptosis in human colorectal cancer cells via p62 regulation of the ATM/γH2AX pathway.
Wang Z; Chen Q; Li B; Xie JM; Yang XD; Zhao K; Wu Y; Ye ZY; Chen ZR; Qin ZH; Xing CG
Acta Pharmacol Sin; 2018 Oct; 39(10):1645-1660. PubMed ID: 29849127
[TBL] [Abstract][Full Text] [Related]
19. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Haga S; Yimin ; Ozaki M
BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
[TBL] [Abstract][Full Text] [Related]
20. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway.
Zhang XR; Wang SY; Sun W; Wei C
Mol Med Rep; 2018 Sep; 18(3):3429-3436. PubMed ID: 30066879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
